Synapse Medicine
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Synapse Medicine?
Synapse Medicine is currently owned by Korelya Capital through K-Fund II (2021 vintage), since 2022. Across its history, Synapse Medicine has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2018 · present
XAngeActive
2018 · present(8yr) · Digital 3 · 2017 · VC
Korelya CapitalActive
2022 · present(4yr) · K-Fund II · 2021 · VC
More from K-Fund II
Other portfolio companies in the same fund.
Spain
Sweden
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
UK
US
Track Synapse Medicine
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Synapse Medicine?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Synapse Medicine.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue